GenVec GNVC

Fundamental analysis difficulties

[investology]

Indeed its financial statements show no sign of a healthy company. Net income for the past 4 quarters have been a negative figure, with no significant improvement over this period.

Their cash flow has also been negative in the most recent quarter. However, total cash flows from operating activities has shown a consistent negative trend. This is a company that will definitely have trouble meeting many of its financial obligations. They were probably breathing a sigh of relief after receiving some much needed grants for its research objectives.

As mentioned, stock issues might be expected sometime in the near future by GenVec. Investor skepticism, given the company's financial health, may not necessarily provide an easy road for GenVec with regards to raising capital.

[amy89]

I believe this company has an extremely narrow road to follow in the next few quarters. As its costs are up by roughly the same amount that its revenue has grown, so it just kind of cancel each other out. There it sits at the same position as before, if not worse. The recent fund given to the company is quite a small amount as r&d goes, it would be quickly burned out. Although it seems to be

[SurajKGupta]

I think they have some good potential for innovation, hence the grant received, however I think that there is no question they should attempt to create more long-term liabilities for themselves instead of attempting to finance their transactions through equity.  They only have $1.2 million in long-term liabilities, and they have$12.3 million in current liabilities that will be paid off within

[buttonwood88]

This stock and company shows some promise.. despite the SP being beaten to oblivion over the last period probably by risk management and traders trying to make a buck on the volatility.